Evidence map›Paper›PMID 31242546›Full record

ArticleMolecules (Basel, Switzerland)2019

Anomeric Spironucleosides of β-d-Glucopyranosyl Uracil as Potential Inhibitors of Glycogen Phosphorylase.

Aggeliki Stathi, Michael Mamais, Evangelia D Chrysina, Thanasis Gimisis

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Frontiers in nutrition · 2023
    Article
  2. Biomimetic Radical Chemistry and Applications.Molecules (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Aggeliki StathiOrganic Chemistry Laboratory, Department of Chemistry, National and Kapodistrian University of Athens, 10571 Athens, Greece. iamaggeliki@yahoo.gr.
Michael MamaisOrganic Chemistry Laboratory, Department of Chemistry, National and Kapodistrian University of Athens, 10571 Athens, Greece. mmamais@chem.uoa.gr.ORCID 0000-0002-7671-6887
Evangelia D ChrysinaInstitute of Chemical Biology, National Hellenic Research Foundation, 11635 Athens, Greece. echrysina@eie.gr.
Thanasis GimisisOrganic Chemistry Laboratory, Department of Chemistry, National and Kapodistrian University of Athens, 10571 Athens, Greece. gimisis@chem.uoa.gr.ORCID 0000-0003-1408-2505
National and Kapodistrian University of Athens · GRNational Hellenic Research Foundation · GR

Funding

Heracleitus II 101Special Account, NKUA 13300
6 · The paper itself

Abstract

In the case of type 2 diabetes, inhibitors of glycogen phosphorylase (GP) may prevent unwanted glycogenolysis under high glucose conditions and thus aim at the reduction of excessive glucose production by the liver. Anomeric spironucleosides, such as hydantocidin, present a rich synthetic chemistry and important biological function (e.g., inhibition of GP). For this study, the Suárez radical methodology was successfully applied to synthesize the first example of a 1,6-dioxa-4-azaspiro[4.5]decane system, not previously constructed via a radical pathway, starting from 6-hydroxymethyl-β-d-glucopyranosyluracil. It was shown that, in the rigid pyranosyl conformation, the required [1,5]-radical translocation was a minor process. The stereochemistry of the spirocycles obtained was unequivocally determined based on the chemical shifts of key sugar protons in the

Indexed as

Enzyme ActivationEnzyme InhibitorsGlycogen PhosphorylaseKineticsMagnetic Resonance SpectroscopyMolecular StructureUracilEnzyme InhibitorsGlycogen PhosphorylaseUracil[1,5]-radical translocation1,6-dioxa-4-azaspiro[4.5]decaneanomeric spironucleosidesglycogen phosphorylasetype 2 diabetes

Identifiers

PMID31242546
PMCPMC6630470
OpenAlexW2946085224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.